Results 131 to 140 of about 411,749 (186)

Pulmonary mucormycosis with bacterial coinfection in an adolescent with poorly controlled type 1 diabetes: a case report. [PDF]

open access: yesFront Endocrinol (Lausanne)
Rong F   +6 more
europepmc   +1 more source

Insulin Detemir

Drugs, 2013
Gillian M Keating
exaly   +3 more sources

Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes

open access: yesDiabetic Medicine, 2007
Aims: This study compared the effect of insulin detemir on glycaemic control (HbA1c, fasting plasma glucose and variability thereof) with that of Neutral Protamine Hagedorn human isophane (NPH) insulin, both combined with insulin aspart, in children with
Johnny Ludvigsson, Z Gucev
exaly   +2 more sources

Insulin detemir: A review

Drugs of Today, 2006
Patients with diabetes are at increased risk of mortality and morbidity from micro- and macrovascular complications (1, 2). Landmark studies in type 1 and 2 diabetes have clearly shown that improved glycemic control leads to better outcomes (3-6). With the introduction of the General Medical Service contract, the England and Wales National Service ...
openaire   +3 more sources

Pharmacology of Insulin Detemir

Endocrinology and Metabolism Clinics of North America, 2007
Insulin detemir (Levemir [Novo Nordisk A/S, Bagsvaerd, Denmark]) is a soluble, long-acting basal insulin analog. It differs from human insulin in that the amino acid threonine in position B30 has been removed and a 14-carbon fatty acid (myristic acid) has been acylated to lysine at B29.
openaire   +2 more sources

Home - About - Disclaimer - Privacy